-Cyanotic CHD, with  Glenn’s shunt (in situ) - SpO2 85% ORA - Hb 17 g/dL - Echo: Patent stent. - Patient on antiplatelet therapy. The gene discussed is GSTM1; the disease is coronary artery disorder.